Company
About HeartSciences
HeartSciences seeks to bridge today’s “diagnostic gap” in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients. HeartSciences has invested years of R&D focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices. HeartSciences’ MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device uses an advanced form of signal processing called continuous wavelet transform (CWT) to extract valuable frequency information from the acquired signal and then analyzes this information using artificial intelligence
HeartSciences initial algorithm provides new information related to a patient’s risk for left ventricular relaxation abnormalities. Most forms of heart disease are associated with left ventricular (LV) relaxation abnormalities and LV diastolic dysfunction¹. Assisting physicians in detecting LV dysfunction in a front-line environment can provide for more effective identification of patients that need referral for additional cardiac testing.
¹LV Diastolic Dysfunction and Prognosis, Dalane W. Kitzman, MD and William C. Little, MD AHA Circ 2012 Feb 14; 125(6): 743–745
Mission
Enabling accurate, affordable screening for the early detection of heart disease.
Leadership
Chairman / CEO
Andrew Simpson Chairman and CEO / Board Member
Andrew has almost 30 years’ experience across a wide variety of business sectors and sizes from small entrepreneurial to large corporate and public companies. He was Group CEO of the Peel
Group from 2006 to 2010.
Peel Group is a large private company in the U.K. with approximately
$8 billion of businesses assets across the real estate, ports, airports, energy, media, telecoms and the environmental sectors. He left after achieving the strategic restructuring of the group by strengthening and creating key divisional teams; introducing key partners into several divisions (including the sale of stakes in its £1.6 billion ports business and £200 million airport business); materially increasing liquid assets by approx. £500 million; divesting non-core assets; and successfully managing £3 billion of debt funding across multiple facilities.
He was a main board director of Speedy Hire plc. (which became a FTSE 250 company) from 2003 to 2006 and was responsible for its development and expansion. This included seventeen acquisitions and several non-core divestments which saw the share price quadruple in value.
Andrew qualified as a Chartered Accountant with Price Waterhouse and spent eight years working in investment banking at Rothschild, advising on a wide variety of M&A transactions, debt and equity fundraisings, IPO’s and shareholder value issues. Andrew graduated first-class honors B.A. (Hons) in Accounting and Management.
Chief Operating Officer
Mark Hilz Chief Operating Officer / Board Member
Mark has over 30 years’ experience as a President/CEO of multiple successful startup companies.
He was previously CEO of INX, a company that he was asked to start as a subsidiary for a public company. The technology infrastructure consulting company was started in 2000 and grew to $400M in revenue with 15 offices, 2,000 customers, and 500 employees. The Company was traded on the NASDAQ, completed multiple offerings and was successfully sold to private equity in December of 2011.
Prior to that Mr. Hilz founded and ran as CEO a technology logistics outsourcing firm, PC Service Source, that grew to over $160 million in revenue with 1,100 employees in an 8-year span. Mr. Hilz raised the startup capital from traditional venture capital sources and after 4 years of operations was successful in taking the Company public in an IPO as a NASDAQ global listed company as well as a successful follow on public offering.
Mark’s experience includes raising venture capital as well as multiple successful public offerings and numerous M&A transactions as both a buyer and a seller.
Board Members
Andrew Simpson Chairman and CEO / Board Member
Andrew has almost 30 years’ experience across a wide variety of business sectors and sizes from small entrepreneurial to large corporate and public companies. He was Group CEO of the Peel
Group from 2006 to 2010.
Peel Group is a large private company in the U.K. with approximately
$8 billion of businesses assets across the real estate, ports, airports, energy, media, telecoms and the environmental sectors. He left after achieving the strategic restructuring of the group by strengthening and creating key divisional teams; introducing key partners into several divisions (including the sale of stakes in its £1.6 billion ports business and £200 million airport business); materially increasing liquid assets by approx. £500 million; divesting non-core assets; and successfully managing £3 billion of debt funding across multiple facilities.
He was a main board director of Speedy Hire plc. (which became a FTSE 250 company) from 2003 to 2006 and was responsible for its development and expansion. This included seventeen acquisitions and several non-core divestments which saw the share price quadruple in value.
Andrew qualified as a Chartered Accountant with Price Waterhouse and spent eight years working in investment banking at Rothschild, advising on a wide variety of M&A transactions, debt and equity fundraisings, IPO’s and shareholder value issues. Andrew graduated first-class honors B.A. (Hons) in Accounting and Management.
Mark Hilz Chief Operating Officer / Board Member
Mark has over 30 years’ experience as a President/CEO of multiple successful startup companies.
He was previously CEO of INX, a company that he was asked to start as a subsidiary for a public company. The technology infrastructure consulting company was started in 2000 and grew to $400M in revenue with 15 offices, 2,000 customers, and 500 employees. The Company was traded on the NASDAQ, completed multiple offerings and was successfully sold to private equity in December of 2011.
Prior to that Mr. Hilz founded and ran as CEO a technology logistics outsourcing firm, PC Service Source, that grew to over $160 million in revenue with 1,100 employees in an 8-year span. Mr. Hilz raised the startup capital from traditional venture capital sources and after 4 years of operations was successful in taking the Company public in an IPO as a NASDAQ global listed company as well as a successful follow on public offering.
Mark’s experience includes raising venture capital as well as multiple successful public offerings and numerous M&A transactions as both a buyer and a seller.
Brian Szymczak Board Member
Brian Szymczak is the lead attorney for Apollo Endosurgery, Inc. in Austin, Texas where he serves as Director of Legal Services. In this role Mr. Szymczak manages legal disputes and litigation matters and provides general legal counsel to the company’s leadership, sales, operations, R&D and human resources groups. Prior to working at Apollo, Mr. Szymczak served as Associate General Counsel and Director of Legal Affairs for a large surgical device manufacturer and previously worked as an associate at the law firm of Baker Botts, LLP where he counseled clients on patent and other intellectual property matters in a variety of technological fields. Mr. Szymczak is a 1999 graduate of Duke University School of Law and holds a Bachelor of Science in Mechanical Engineering from Texas A&M University.
David R. Wells Board Member
Mr. Wells brings over 30 years of senior financial management experience. Most recently, he founded Atlas Bookkeeping, LLC, a technology-based financial services firm that provides bookkeeping and reporting services for emerging growth and small cap public and privately held companies. Prior to Atlas, Mr. Wells served as Chief Financial Officer of GHS Investments, LLC, a privately held “super value” fund focused on investing in small-to-mid cap companies. Mr. Wells also served as Chief Financial Officer of ENDRA Life Sciences (Nasdaq: NDRA), a publicly traded clinical diagnostics technology company. Mr. Wells directed ENDRA’s initial public offering and subsequently helped raise an additional $55 million across multiple transactions. Previously, David founded Wells Compliance Group, a technology-based services firm supporting the financial reporting needs of publicly traded companies and privately held firms. Additionally, David held numerous Chief Financial Officer, Vice President of Finance, and Senior Business Analyst positions. David began his career as a consultant to various start-up and growing companies. David holds a Master of Business Administration from Pepperdine University with a focus in Finance and a Bachelor of Science degree in Finance and Entrepreneurship from Seattle Pacific University.
Bruce Bent Board Member
Mr. Bent brings more than thirty-five years of experience in financial management and fifteen years of experience in financing, early stage investing and acquisitions to HeartSciences Board. Mr Bent has held a variety of executive positions at The Matthews Group including Controller, CFO and President of various Canadian companies. He was integral in Matthews completion of “The Bow” a $1.7 billion corporate headquarters for Encana. Mr Bent’s finance and operations experience at Matthews and other entities give him a breadth of knowledge in the both finance and fund raising which will be very helpful to HeartSciences in this phase of its development.
Mr. Bent is Chairman of Enerdynamic Hybrid Technologies Corp. a TSXV listed public company involved in the development of renewable energy products. In addition Mr Bent serves in the same capacity for Astro Aerospace Ltd an OTC listed public company focused on the EVTL space.
Mr. Bent graduated from the University of Manitoba with a Bachelor of Commerce (honours) and obtained his Chartered Professional Accounting designation from the Province of Ontario.
Management
Andrew Simpson Chairman and CEO / Board Member
Andrew has almost 30 years’ experience across a wide variety of business sectors and sizes from small entrepreneurial to large corporate and public companies. He was Group CEO of the Peel
Group from 2006 to 2010.
Peel Group is a large private company in the U.K. with approximately
$8 billion of businesses assets across the real estate, ports, airports, energy, media, telecoms and the environmental sectors. He left after achieving the strategic restructuring of the group by strengthening and creating key divisional teams; introducing key partners into several divisions (including the sale of stakes in its £1.6 billion ports business and £200 million airport business); materially increasing liquid assets by approx. £500 million; divesting non-core assets; and successfully managing £3 billion of debt funding across multiple facilities.
He was a main board director of Speedy Hire plc. (which became a FTSE 250 company) from 2003 to 2006 and was responsible for its development and expansion. This included seventeen acquisitions and several non-core divestments which saw the share price quadruple in value.
Andrew qualified as a Chartered Accountant with Price Waterhouse and spent eight years working in investment banking at Rothschild, advising on a wide variety of M&A transactions, debt and equity fundraisings, IPO’s and shareholder value issues. Andrew graduated first-class honors B.A. (Hons) in Accounting and Management.
Mark Hilz Chief Operating Officer / Board Member
Mark has over 30 years’ experience as a President/CEO of multiple successful startup companies.
He was previously CEO of INX, a company that he was asked to start as a subsidiary for a public company. The technology infrastructure consulting company was started in 2000 and grew to $400M in revenue with 15 offices, 2,000 customers, and 500 employees. The Company was traded on the NASDAQ, completed multiple offerings and was successfully sold to private equity in December of 2011.
Prior to that Mr. Hilz founded and ran as CEO a technology logistics outsourcing firm, PC Service Source, that grew to over $160 million in revenue with 1,100 employees in an 8-year span. Mr. Hilz raised the startup capital from traditional venture capital sources and after 4 years of operations was successful in taking the Company public in an IPO as a NASDAQ global listed company as well as a successful follow on public offering.
Mark’s experience includes raising venture capital as well as multiple successful public offerings and numerous M&A transactions as both a buyer and a seller.
Danielle Watson Chief Financial Officer
Danielle Watson has served as our Chief Financial Officer since April 2022. Prior to her appointment, Ms. Watson, a CPA, served as the Company’s Financial Controller since November 2021. Ms. Watson brings over 15 years of financial experience to her role. Before joining HeartSciences, Ms. Watson held senior leadership roles at Moss Adams, LLP from November 2007 to November 2021 where she provided audit and assurance services to both public and privately held companies with an emphasis in financial reporting, consolidations, strategic planning, purchase price accounting, and SEC reporting. Ms. Watson earned her Bachelor of Science, with a double concentration in accounting and finance from Texas Christian University and her Master of Science in accounting from the University of Texas at Arlington and is an active Certified Public Accountant in Texas.
Aaron Peterson VP Research and Development
Aaron is a highly experienced technical professional and leader in the Medical Device industry. He has nearly 25 years of Engineering, Product Development, and Management experience at some of the most reputable Medical Device companies such as St. Jude Medical, Boston Scientific, and Guidant. Aaron has successfully productized multiple innovative technologies from concept through production in the areas of Cardiac Rhythm Management and Neuromodulation. Many of these innovations enabled the introduction of new products to a somewhat commoditized market, resulting in significant sales growth for the business as well as overall growth in the market. Aaron is co-author on multiple patents and has received various technical awards throughout his career. Aaron is also an active influencer in the Medical Device industry and is a member of the Board of Trustees for the International Society of Computerized Electrocardiography.
Isabella Schmitt, RAC, MBA
With a diverse background spanning regulatory affairs, clinical trial design and management, product management, and quality assurance, Isabella has a unique blend of expertise to drive success for any medtech program. She has guided regulatory, quality, and clinical initiatives for over 100 successful regulatory filings and FDA interactions. She has also authored articles for multiple publications, participated in numerous podcasts, and engaged in speaking opportunities covering regulatory affairs submissions and interactions for medical devices and AI/ML in healthcare. As a member of the AAMI/ISO Standards working group, she also helped to establish Application Of ISO 14971 To Machine Learning In Artificial Intelligence. She has a RAC Certification, Master’s in Business Administration, and a Bachelor’s of Science in Chemistry and has won awards for success in business, including the Stevie’s Business Award as well as Houston Business Journal’s Award for Women to Watch.
Scientific Advisors
Ben Glicksberg, Ph.D.
Dr. Glicksberg was an Assistant Professor in AI for Human Health and Genetics and Genomic Sciences at the Ichan School of Medicine at Mount Sinai, where he led a team using machine learning on multi-modal and multi-omic patient data for personalizing medicine. His research applications range from predictive modeling to drug discovery. Dr. Glicksberg received his Ph.D. from the Ichan School of Medicine at Mount Sinai and completed his post-doctoral work at the University of California, San Francisco.
Jordan Strom, MD, MSc
Dr. Jordan Strom is Director of the Echocardiography Laboratory and Director of Echocardiographic Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts, Assistant Professor of Medicine at Harvard Medical School, and Section Head for Cardiovascular Imaging Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. His research which has been funded by the NIH (including a K23 award and recent R01 grant) and American Heart Association involves evaluation of the relationship of cardiac structure and function to health outcomes and the optimal use and timing of cardiac imaging in practice. He has published more than 90 papers in peer-reviewed journals and is a member of the Editorial Board of and guest editor for the Journal of the American Society of Echocardiography. He additionally served as the inaugural American Society of Echocardiography (ASE) leadership academy member elected to the Board of Directors of the ASE, making him the youngest individual to serve in this role, and the American College of Cardiology Imaging Council Leadership Committee. He is a member of the Board of Directors of the International Contrast Ultrasound Society, and is the current American College of Cardiology representative to the Board of Directors of the Joint Review Committee on Education in Diagnostic Medical Sonography, which accredits sonography training programs in the United States as well as ACC Commissioner to the Commission on Accreditation of Allied Health Education Programs (CAAHEP), the largest programmatic accreditor of the health sciences professions, accrediting over 2,100 education programs in 32 health sciences occupations.
Dr. Partho P. Sengupta, MD, MBBS, FACC
Dr. Sengupta is the Henry Rutgers Professor and the Chief of Division of Cardiology at Rutgers Robert Wood Johnson Medical School and the Robert Wood Johnson University Hospital. Previously, Dr. Sengupta was the Abnash C. Jain Chair & Professor of Cardiology at West Virginia University School of Medicine and the Chief of Division of Cardiology, Chair of Cardiovascular Innovation and Director of Cardiac Imaging at West Virginia University Heart and Vascular Institute.
Dr. Sengupta has over 300 peer-reviewed publications and is an Associate Editor for the Journal of American College of Cardiology for Cardiovascular Imaging. He served on the Board of Directors for the American Society of Echocardiography (ASE) and as the Chair of the ASE Telehealth and New Technology Taskforce. He was a TEDMED speaker, presenting on “Using Holography to Reshape Cardiology”. Dr. Sengupta has also won numerous excellence awards and has been recognized by international societies including the American Society of Echocardiography, American Medical Association, European Society of Cardiology and British Society of Echocardiography for his roles in education and innovation. In addition, some of his notable awards consist of the American Society of Echocardiography Young Investigator Award in 2004, Mayo Clinic Research Award in 2007, Mayo Brother’s Distinguished Fellowship Award in 2009, and AACIO Young Investigator Award in 2010. In 2013, he received the ASE’s 14th Feigenbaum Lectureship for his significant contributions to research in the field of echocardiography. In 2020, Dr. Sengupta was named a Richard Popp Excellence in Teaching Award recipient by the American Society of Echocardiography. In 2020 Dr. Sengupta and a group of researchers led by Dr. Sengupta won the National Heart, Lung, and Blood Institute big data analysis challenge for creating innovative paradigms in heart failure research. Most recently, he was awarded the Gifted Educator Award, American College of Cardiology – Distinguished Awards.